… isolates collected prospectively in 2016 from medical centres in the Asia-Pacific (3443
isolates), Europe (13 530 isolates), Latin America (3327 isolates) and the USA (13 048 isolates). …

… clinical isolates of Enterobacteriaceae, including isolates that … in which data for isolates from
the Asia-Pacific region have … in certain countries within the Asia-Pacific region than in other …

… nonduplicate bacterial isolates collected prospectively during … Asia-Pacific (11,397 isolates),
Europe (23,490 isolates), Latin America (8,038 isolates), and North America (26,321 isolates…

… Asia–Pacific region. The aims of this study were to measure the rates of resistance among
clinical isolates collected in Asia–Pacific … –avibactam and comparators against these isolates. …

… The overall mutation rates among clinical isolates remain low (C. glabrata complex, ∼4%;
other species: <1%) and the rates are higher with prior echinocandin exposure, exceeding 50…

… the Clinical Laboratory Standards Institute. Eight hundred and sixty-one Candida isolates
were … This study demonstrates that non- albicans species are the most common isolates from …

… The mechanism of colistin resistance acquired in the clinical isolates was beyond the
scope of our analysis. However, monitoring the antibiotic susceptibility trend of colistin in …

… ) depending on the length of time between collection of clinical specimens for the recovery
of isolates and hospitalisation; isolates were classified as CA if they were obtained within 48 h …

… isolates from the region. C. difficile isolates (n = 414) from a 2014 study of 13 Asia-Pacific …
according to the Clinical and Laboratory Standards Institute’s agar dilution method. All …

… the in vitro activity of aztreonam/avibactam against clinical Enterobacterales isolates. …
Our results support clinical development of aztreonam/avibactam to treat infections caused by …